Vaxart, Inc. (VXRT) Financial Statements

Income statement

Metric	TTM	2025	2024	2023	2022
Revenue
Total Revenue	243.1M	237.3M	28.7M	7.4M	107.0K
Cost of Revenue	—	—	—	4.5M	—
Gross Profit	243.1M	237.3M	28.7M	2.9M	107.0K
Operating Expenses
R&D Expense	184.3M	201.6M	74.2M	68.1M	81.1M
SG&A Expense	19.2M	17.6M	20.8M	22.6M	29.4M
General & Admin Expense	19.2M	17.6M	20.8M	22.6M	29.4M
Selling & Marketing Expense	—	—	—	—	—
Other Expenses	—	—	—	(4.5M)	4.3M
Total Operating Expenses	203.5M	219.2M	95.0M	86.2M	114.7M
Cost and Expenses	203.5M	219.2M	95.0M	90.7M	114.7M
Operating Income (EBIT)	39.6M	18.1M	(66.3M)	(83.3M)	(114.6M)
Non-Operating
Interest Income	2.0M	1.6M	2.5M	2.7M	1.2M
Interest Expense	2.2M	2.8M	3.0M	1.4M	1.3M
Net Interest Income	(219.0K)	(1.2M)	(426.0K)	1.2M	(58.0K)
Other Non-Op Income/Expense	(605.0K)	(1.3M)	(395.0K)	1.1M	6.9M
Non-Operating Income (excl Interest)	(1.6M)	(1.6M)	(2.6M)	(2.6M)	(8.2M)
EBT (Pre-Tax Income)	39.0M	16.8M	(66.7M)	(82.2M)	(107.7M)
Income Tax Expense	419.0K	476.0K	260.0K	261.0K	67.0K
Bottom Line
Net Income	38.6M	16.3M	(66.9M)	(82.5M)	(107.8M)
Earnings from Cont. Ops	38.6M	16.3M	(66.9M)	(82.5M)	(107.8M)
Earnings from Discont. Ops	—	—	—	—	—
Bottom Line Net Income	38.6M	16.3M	(66.9M)	(82.5M)	(107.8M)
Per Share
Basic EPS	$0.15	$0.07	($0.14)	($0.17)	($0.22)
Diluted EPS	$0.15	$0.07	($0.14)	($0.17)	($0.22)
Revenue Per Share	$1.00	$1.03	$0.06	$0.02	$0.00
Shares
Basic Shares Outstanding	242.2M	230.3M	487.3M	487.3M	487.3M
Diluted Shares Outstanding	242.2M	230.3M	487.3M	487.3M	487.3M
Profitability Metrics
EBITDA	47.2M	28.2M	(54.9M)	(72.1M)	(100.6M)
D&A	6.0M	8.6M	8.8M	8.6M	5.8M
EBIT	41.2M	19.6M	(63.7M)	(80.8M)	(106.4M)

As reported, in the filing currency · TTM sums the four latest quarters; MRQ is the latest quarter · Negatives in parentheses; a dash is a line the filing does not carry · Data as of Jun 1, 2026